Show simple item record

dc.contributor.authorTungaraza, Tongeji E.
dc.contributor.authorTalapan-Manikoth, Pravija
dc.contributor.authorJenkins, Rosemary
dc.date.accessioned2023-08-23T12:03:47Z
dc.date.available2023-08-23T12:03:47Z
dc.date.issued2013-04
dc.identifier.citationTungaraza TE, Talapan-Manikoth P, Jenkins R. Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatry. Ther Adv Drug Saf. 2013 Apr;4(2):63-71. doi: 10.1177/2042098612474681. PMID: 25083252; PMCID: PMC4110830.en_US
dc.identifier.issn2042-0986
dc.identifier.doi10.1177/2042098612474681
dc.identifier.pmid25083252
dc.identifier.urihttp://hdl.handle.net/20.500.14200/1892
dc.description.abstractOrally taken tablets in different formulations continue to have a central role in the treatment of various psychiatric and medical conditions. In order to improve compliance, reduce the frequency of taking medications and minimize the peaks and troughs associated with certain immediate-release formulations, pharmaceutical companies have developed a number of novel methods of delivering oral solid dosage medications in the form of controlled-release (CR) formulations. Some CR formulations have been associated with pharmacobezoars and false-positive findings on certain physical investigations. Though CR drugs are commonly used in psychiatry, clinicians appear to have a limited understanding of how they are released for absorption once ingested. Some have insoluble parts that are excreted in faeces as 'ghost pills'. Due to lack of awareness of this phenomenon to both patients and the physicians, anxiety has ensued in some patients. Some clinicians have been puzzled or have been dismissive when faced with curious patients wanting to know more after they had observed tablet-like looking structures in faeces. We present two cases from our clinical setting and a few drawn from the World Wide Web to highlight the role of CR medications and their association with the ghost pill phenomenon. The mechanisms involved in drug release relevant to psychiatry medications are also briefly reviewed. The ghost pill phenomenon occurs with certain CR medications. This is a normal and expected outcome related to drug-release mechanisms of some of these products. It is inevitable that some patients will see what looks like tablets or capsules in faeces. Raising awareness of this phenomenon among clinicians would facilitate discussions and information sharing at the initial process of medication prescribing. Awareness among patients and carers would also help to allay anxiety.en_US
dc.language.isoenen_US
dc.publisherSAGE Publicationsen_US
dc.subjectMental healthen_US
dc.subjectPharmacologyen_US
dc.titleCurse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatryen_US
dc.typeArticle
dc.source.journaltitleTherapeutic Advances in Drug Safety
dc.source.volume4
dc.source.issue2
dc.source.beginpage63
dc.source.endpage71
dc.source.countryEngland
rioxxterms.versionAOen_US
dc.contributor.affiliationBlack Country Partnership Foundation Trust, Psychiatry, Penn Hospital, Penn Road, Wolverhampton WV4 5HN, UK.en_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record